about
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment compr...
Read More
90.00
-6.92
(-7.14%)
2.7M
XNAS Volume
High volume+loss today
XNAS 29 Dec, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Merus N.V Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..